Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 19, 2011

View Archived Issues

New agents target pathways involved in antipsychotic drug response

New candidate immunotherapies for ovarian cancer developed in Japan

Results presented from pilot study of Panvac vaccine

First-in-class mitotic kinase inhibitor shows anticancer properties

New antimicrobials show promise to treat urinary tract infections

Vertex patents new ATR inhibitors for cancer

BioSante Pharmaceuticals reports new phase III LibiGel data

Endocyte's PRECEDENT trial results confirmed by supplemental analyses

FDA grants orphan drug status to Pinnacle Biologics product

Novel PRCP inhibitors discovered at Merck & Co.

Array BioPharma patents new GPR119 receptor agonists

Takeda synthesizes novel TGFR-1 inhibitors

Merck & Co. reports new antihypertensive drugs

Gilead Sciences claims new antiviral products

NeuroSearch's SK channel research passed to new spin-out

Novartis Pharma stops clinical development of SMC-021

Treatment begins in phase III Benlysta trial

Trillium set to begin phase I TTI-1612 trial in Canada

Novartis' third phase III Gilenya study confirms previous encouraging outcomes

Soligenix begins to develop next-generation anthrax vaccine

AtheroNova plans IND submission for AHRO-001

FDA sets action date for Dymista NDA

Isis Pharmaceuticals provides update on NDA submission for mipomersen sodium

Prana Biotechnology begins recruitment in phase II PBT-2 trial

Hybrigenics completes enrollment in phase II inecalcitol trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...